Document 2996
 DOCN  M94A2996
 TI    Survival impact of prior opportunistic infection (OI) of Kaposi's
       sarcoma (KS) among AIDS related lymphomas (ARL).
 DT    9412
 AU    Schmilovich A; Perez H; Gil Deza E; Marantz A; Savignano R; Cahn P;
       Acad. Mac. de Medicina, Buenos Aires, Argentina.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):177 (abstract no. PB0133). Unique
       Identifier : AIDSLINE ICA10/94369579
 AB    Many prognostic factors had been studied in ARL with controversial
       results but uniformly previous OI and/or KS are useful to indentify a
       group of patients (pts) with poor survival (S). Between 3/87 and 6/93,
       31 pts with ARL were treated with mono or polichemotherapy at three
       single institutions in Argentina. We analized in a retrospective study
       the impact of previous OI and/or KS on S. Characteristics of pts without
       (A) or with (B) prior OI and/or KS are shown below. TABULAR DATA, SEE
       ABSTRACT VOLUME. CONCLUSIONS: 1- ARL in B are associated with poor
       performance status (PS) low CD4 level and poor S; 2- Nor Bulky Disease,
       Stage III-IV or response rate shown differences between both groups.
 DE    Acquired Immunodeficiency Syndrome/*MORTALITY/PATHOLOGY/THERAPY  Adult
       Aged  Argentina  AIDS-Related Opportunistic
       Infections/*MORTALITY/PATHOLOGY/  THERAPY  Combined Modality Therapy
       Female  Follow-Up Studies  Human  Lymphoma,
       AIDS-Related/*MORTALITY/PATHOLOGY/THERAPY  Male  Middle Age  Neoplasm
       Staging  Neoplasms, Multiple Primary/*MORTALITY/PATHOLOGY/THERAPY
       Retrospective Studies  Sarcoma, Kaposi's/*MORTALITY/PATHOLOGY/THERAPY
       Skin Neoplasms/*MORTALITY/PATHOLOGY/THERAPY  Survival Rate  MEETING
       ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).